NASDAQ:CNSP | Income Statement | CNS Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.2M$2.7M-$2.7M$112,000.00-$2.59M-$0.38-$0.386,838,2056,838,205
2026-03-31$3.54M$4.98M-$4.98M$38,159.00-$4.94M-$7.30-$7.30676,172676,172
2025-12-31$3.17M$5.99M-$5.99M$30,324.00-$5.96M-$10.15-$10.1556,82156,821
2025-09-30$2.2M$3.25M-$3.25M$34,907.00-$3.22M-$5.76-$5.76558,868558,868
2025-06-30$1.17M$2.41M-$2.41M$34,000.00-$2.38M-$6.42-$6.42370,127370,127
2025-03-31$3.24M$4.34M-$4.34M$36,340.00-$4.3M-$18.93-$18.93227,220227,220
2024-12-31$1.5M$3.2M-$3.2M$23,682.00-$3.18M$460.87$460.8719,23219,232
2024-09-30$4.24M$5.63M-$5.63M$22,972.00-$5.61M-$153.20-$153.2036,59336,593
2024-06-30$1.12M$2.53M-$2.53M-$2,618.00-$2.53M-$4,049.20-$4,049.20625625
2024-03-31$2.43M$3.54M-$3.54M$106.00-$3.54M-$1,020.48-$1,020.483,4743,474
2023-12-31$4.27M$5.38M-$5.38M$4,121.00-$5.38M-$12,306.63-$12,306.63-65,046-65,046
2023-09-30$3.41M$4.53M-$4.53M$11,045.00-$4.52M-$54.14-$54.1483,54283,542
2023-06-30$2.85M$4.03M-$4.03M$4,152.00-$4.02M-$51.86-$51.8677,54777,547
2023-03-31$3.57M$4.93M-$4.93M-$5,436.00-$4.93M-$2.59-$2.591,906,4941,906,494
2022-12-31$2.98M$5.13M-$5.13M-$2,312.00-$5.14M-$3.55-$3.5540,67240,672
2022-09-30$2.21M$3.42M-$3.42M-$538.00-$3.42M-$2.56-$2.561,334,4171,334,417
2022-06-30$2.22M$3.56M-$3.56M-$1,611.00-$3.57M-$2.67-$2.671,334,4171,334,417
2022-03-31$1.89M$3.15M-$3.15M-$2,566.00-$3.15M-$2.44-$2.441,293,6121,293,612
2021-12-31$2.36M$3.25M-$3.25M-$2,238.00-$3.25M-$16.07-$16.07-24,979,778-24,979,778
2021-09-30$2.58M$3.81M-$3.81M-$947.00-$3.81M-$0.14-$0.1427,443,77127,443,771
2021-06-30$2.66M$3.81M-$3.81M-$2,353.00-$3.81M-$0.15-$0.1525,432,71725,432,717
2021-03-31$2.21M$3.61M-$3.61M-$3,747.00-$3.61M24,664,394
2020-12-31$1.91M$3M-$3M-$3,264.00-$3M157,109
2020-09-30$1.04M$2.01M-$2.01M$0.00-$2.01M16,483,529
2020-06-30$1.49M$2.47M-$2.47M$0.00-$2.47M16,450,234
2020-03-31$613,077.00$1.97M-$1.97M$0.00-$1.97M16,450,234
2019-12-31$1.44M$2.52M-$2.52M-$3,617.00-$2.53M474,728
2019-09-30$325,634.00$699,094.00-$699,094.00-$7,561.00-$706,655.0013,573,817
2019-06-30$42,730.00$415,062.00-$415,062.00-$16,645.00-$431,707.0013,202,856
2019-03-31$48,307.00$195,090.00-$195,090.00-$211,501.0012,694,504
2018-12-31$0.00$208,583.00-$208,583.00-$6.63M16,638
2018-09-30$4,600.00$169,905.00-$169,905.00-$193,204.0010,493,913
2018-06-30-$257,483.00
2018-03-31-$309,699.00

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$9.77M$15.99M-$15.99M$135,995.00$0.00-$15.85M-$35.75-$35.75443,369443,369
2024-12-31$9.29M$14.9M-$14.9M$44,142.00$0.00-$14.86M-$466.89-$466.8931,82331,823
2023-12-31$14.1M$18.87M-$18.87M$13,882.00$0.00-$18.85M-$12,509.11-$12,509.111,5071,507
2022-12-31$9.3M$15.27M-$15.27M-$7,027.00$0.00-$15.27M-$11.22-$11.221,361,7371,361,737
2021-12-31$9.81M$14.49M-$14.49M-$9,285.00$0.00-$14.5M-$16.50-$16.50878,443878,443
2020-12-31$5.06M$9.45M-$9.45M-$3,264.00$0.00-$9.46M16,618,441
2019-12-31$1.85M$3.83M-$3.83M-$44,234.00$0.00-$3.88M13,647,908
2018-12-31$21,267.00$881,787.00-$881,787.00-$6.51M$0.00-$7.39M10,510,551